142 related articles for article (PubMed ID: 20374079)
21. [Evaluation of myelin basic protein levels with receiver operating characteristic curves for diagnosis of multiple sclerosis].
Tian ZJ; Zhao XX; Li ZH; Zhang F; Cao FT; Li SM; Shao M; Dong YX
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):250-2. PubMed ID: 19246291
[TBL] [Abstract][Full Text] [Related]
22. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
Shimada K; Koh CS; Yanagisawa N
Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.
Yonekura K; Yokota S; Tanaka S; Kubota H; Fujii N; Matsumoto H; Chiba S
J Neuroimmunol; 2004 Nov; 156(1-2):204-9. PubMed ID: 15465612
[TBL] [Abstract][Full Text] [Related]
24. Glial fibrillary acidic protein: a marker of axonal Guillain-Barrè syndrome and outcome.
Notturno F; Caporale CM; De Lauretis A; Uncini A
Muscle Nerve; 2008 Jul; 38(1):899-903. PubMed ID: 18508349
[TBL] [Abstract][Full Text] [Related]
25. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome.
Demircan N; Gurel A; Armutcu F; Unalacak M; Aktunc E; Atmaca H
Med Sci Monit; 2008 Feb; 14(2):CR97-101. PubMed ID: 18227768
[TBL] [Abstract][Full Text] [Related]
26. Serum uric acid levels of patients with multiple sclerosis and other neurological diseases.
Peng F; Zhang B; Zhong X; Li J; Xu G; Hu X; Qiu W; Pei Z
Mult Scler; 2008 Mar; 14(2):188-96. PubMed ID: 17942520
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress status in patients with diabetes mellitus: relationship to diet.
Dierckx N; Horvath G; van Gils C; Vertommen J; van de Vliet J; De Leeuw I; Manuel-y-Keenoy B
Eur J Clin Nutr; 2003 Aug; 57(8):999-1008. PubMed ID: 12879095
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma.
Zima T; Spicka I; Stípek S; Crkovská J; Pláteník J; Merta M; Tesar V
Neoplasma; 1996; 43(2):69-73. PubMed ID: 8843965
[TBL] [Abstract][Full Text] [Related]
29. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis.
Melø TM; Larsen C; White LR; Aasly J; Sjøbakk TE; Flaten TP; Sonnewald U; Syversen T
Biol Trace Elem Res; 2003; 93(1-3):1-8. PubMed ID: 12835484
[TBL] [Abstract][Full Text] [Related]
30. Alterations of plasma concentrations of lipophilic antioxidants are associated with Guillain-Barre syndrome.
Tang HY; Ho HY; Chiu DT; Huang CY; Cheng ML; Chen CM
Clin Chim Acta; 2017 Jul; 470():75-80. PubMed ID: 28476374
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
[TBL] [Abstract][Full Text] [Related]
32. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
Lehmensiek V; Süssmuth SD; Brettschneider J; Tauscher G; Felk S; Gillardon F; Tumani H
J Neuroimmunol; 2007 Apr; 185(1-2):190-4. PubMed ID: 17367871
[TBL] [Abstract][Full Text] [Related]
33. [CSF filtration and interferon-beta for Guillain-Barré syndrome].
Odaka M
Nihon Rinsho; 2008 Jun; 66(6):1200-4. PubMed ID: 18540371
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
35. Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis.
Keles MS; Taysi S; Sen N; Aksoy H; Akçay F
Can J Neurol Sci; 2001 May; 28(2):141-3. PubMed ID: 11383939
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.
Péter M; Török W; Petrovics-Balog A; Vígh L; Vécsei L; Balogh G
Sci Rep; 2020 Oct; 10(1):18380. PubMed ID: 33110173
[TBL] [Abstract][Full Text] [Related]
37. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
Patzold T; Sindern E; Ossege-Pohle L; Malin JP
J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
[TBL] [Abstract][Full Text] [Related]
38. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
Vedeler CA; Matre R; Sadallah S; Schifferli J
J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
[TBL] [Abstract][Full Text] [Related]
39. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.
Bourque PR; Brooks J; Warman-Chardon J; Breiner A
J Neurol; 2020 Mar; 267(3):746-751. PubMed ID: 31734909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
